Highly pathogenic avian influenza A(H5N1) mutants transmissible by air are susceptible to human and animal neutralizing antibodies.

A laboratory-generated reassortant H5 hemagglutinin (HA)/influenza A(H1N1) strain containing 4 mutations in influenza A(H5N1) HA has become transmissible by air among mammals. Here, we constructed 15 influenza A(H5N1) pseudoviruses containing a single mutation or a combination of mutations and showed that the pseudoviruses were susceptible to neutralizing antibodies from patients with influenza A(H5N1) infection and from mice immunized with a vaccine containing the conserved HA1 sequence of influenza A(H5N1). These results indicate that antibodies in patients currently infected by influenza A(H5N1) and antibodies induced by vaccines containing conserved sequences in HA1 of wild-type influenza A(H5N1) are highly effective in cross-neutralizing future influenza A(H5N1) mutants with airborne transmissibility, suggesting that human influenza pandemics caused by these influenza A(H5N1) variants can be prevented.

[1]  Shibo Jiang,et al.  A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection , 2013, PloS one.

[2]  R. Liddington,et al.  Identification and Structural Characterization of a Broadly Neutralizing Antibody Targeting a Novel Conserved Epitope on the Influenza Virus H5N1 Hemagglutinin , 2012, Journal of Virology.

[3]  Marc Lipsitch,et al.  Rethinking Biosafety in Research on Potential Pandemic Pathogens , 2012, mBio.

[4]  Theo M Bestebroer,et al.  Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.

[5]  David L Smith,et al.  The Potential for Respiratory Droplet–Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host , 2012, Science.

[6]  Michael T. Osterholm,et al.  Mammalian-Transmissible H5N1 Influenza: Facts and Perspective , 2012, mBio.

[7]  Johannes Rath.  Mutant flu: assessing biosecurity risks , 2012, Nature.

[8]  E. Starbuck.  Mutant flu: preparing for a pandemic , 2012, Nature.

[9]  A. Casadevall,et al.  Adaptations of Avian Flu Virus Are a Cause for Concern , 2012, Science.

[10]  R. Webster,et al.  Mammalian-Transmissible H5N1 Influenza: the Dilemma of Dual-Use Research , 2012, mBio.

[11]  Jie Zhou,et al.  A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses , 2011, PloS one.

[12]  Hong-xia Yu,et al.  Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies , 2010, Biochemical and Biophysical Research Communications.

[13]  K. Subbarao,et al.  Glycosylation at 158N of the Hemagglutinin Protein and Receptor Binding Specificity Synergistically Affect the Antigenicity and Immunogenicity of a Live Attenuated H5N1 A/Vietnam/1203/2004 Vaccine Virus in Ferrets , 2010, Journal of Virology.